Taft-Hartley Trust

The Taft-Hartley Trust, also known as a Taft-Hartley Health and Welfare Fund, is a type of multi-employer trust that provides employee benefits to unionized workers in various industries. It was created as a result of the Taft-Hartley Act of 1947, which allows unions and employers to negotiate for certain benefits to be provided through jointly-managed trusts.

Key features of a Taft-Hartley Trust include:

  • Joint management: The trust is managed by both union and employer representatives, who work together to determine the benefits provided and the funding sources.

  • Multi-employer: The trust covers employees of multiple employers who are signatories to the collective bargaining agreement with the union.

  • Health and welfare benefits: The trust typically provides a range of benefits, including health insurance, dental and vision coverage, life insurance, disability insurance, and retirement benefits.

  • Funding: The trust is funded through employer contributions, negotiated as part of the collective bargaining agreement, and in some cases, employee contributions.

  • Portability: Because the benefits are provided through the trust, rather than through a specific employer, they are portable, meaning that employees can continue to receive the benefits even if they change employers.

Taft-Hartley Trusts have become an important way for unions to provide benefits to their members, particularly in industries where employment is often transient and workers move between different employers. They also provide employers with a way to offer competitive benefits to their employees, while sharing the cost of providing those benefits with other employers in the industry.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.